Services on Demand
Journal
Article
Indicators
Cited by SciELO
Related links
Similars in SciELO
Share
Acta Médica Peruana
On-line version ISSN 1728-5917
Abstract
AZANEDO, Diego et al. Quality of metabolic control in outpatients with type 2 diabetes seen in a private clinic. Acta méd. Peru [online]. 2017, vol.34, n.2, pp.106-113. ISSN 1728-5917.
Objective: To assess the quality of metabolic control among outpatients with type 2 diabetes mellitus (DM2) in a private clinic in Lima, Peru. Materials and methods: This is a cross-sectional study in the outpatient endocrinology service of a private clinic in Lima, Peru. Socio-demographic information, history of diabetes, self-report of complications and comorbidities, anthropometric measures and blood pressure data were collected. Blood samples were taken for assessing fasting blood glucose, glycated hemoglobin (HbA1c) and lipid profile. A poor metabolic control was considered if the participant had HbA1c >7%, LDL cholesterol (LDL-c) =100 mg/dl, and blood pressure =130/80 mmHg. Additional questionnaires were administered for measuring adherence to therapy, physical activity, quality of life, self-efficacy and depression. Results: Sixty participants were included; 53.3% (32/60) were female and their mean age was 63.1 ±13.2 years. Poor metabolic control was found in 85% (51/60) of all participants; controlled blood pressure in 71.2% (42/60), controlled LDL-C levels in 10% (6/60), and controlled HbA1c values in 48.3% (29/60) participants, respectively. Chronic complications such as retinopathy were found in 3.33% (2/60) participants, neuropathy in 10% (6/60), nephropathy in 1.7% (1/60), high blood pressure in 30% (18/60) and cerebrovascular disease in 5% (3/60) of all participants. Conclusion: There is a high prevalence of poor metabolic control in patients with type 2 diabetes, despite being taken care of in a private clinic. It is necessary to take actions in order to improve the metabolic control in patients with type 2 diabetes attending the private health care sector
Keywords : Diabetes mellitus, type 2; Health facilities, proprietary; Metabolism.